#TILS $TLSA - research note:

Listing- AIM / NASDAQ
Price- 57.5p
52wk High- 162p
MC- £92.3M
Issue- 160M
FreeFloat- 40%
Director holding- 40%
IP / Tech- Foralumab, Milciclib, Anti il-6r, StemPrintER

Cont.
#TILS $TLSA - IP & Tech:

Foralumab - immunotheraputic - market size $127B (just cancer)

Milciclib - Oncology (cell regulator) - market size $176B

IL-6 inhibitor - Autoimmune & COVID-19 - market size TBD

StemPrintER - Breast Cancer Diagnostic - market size $4.64B

Cont.
#TILS $TLSA - IL-6 & Covid-19:

Study launched into TILS fully human IL-6 inhibitor in relieving covid symptoms.

Patent filed on unique inhaler delivery system.

Recent acquisition of IP with Covid applications.

Covid put TILS on the map, however,,,,,

Cont.
#TILS $TLSA - IL-6 & Covid-19:Study launched into TILS fully human IL-6 inhibitor in relieving covid symptoms.Patent filed on unique inhaler delivery system. Recent acquisition of IP with Covid applications. Covid put TILS on the map, however,,,,,Cont.
#TILS $TLSA - IL-6 & Covid-19:Study launched into TILS fully human IL-6 inhibitor in relieving covid symptoms.Patent filed on unique inhaler delivery system. Recent acquisition of IP with Covid applications. Covid put TILS on the map, however,,,,,Cont.
#TILS $TLSA - StemPrintER

You came for the covid, but will stay for the breast!

StemPrintER is a breast cancer diagnostic assay that is generating big interest lately after it emerged ASCO are minded to deem this tech best in class.

"So what?" I hear you ask. Read on.

Cont.
#TILS $TLSA - StemPrintERYou came for the covid, but will stay for the breast! StemPrintER is a breast cancer diagnostic assay that is generating big interest lately after it emerged ASCO are minded to deem this tech best in class."So what?" I hear you ask. Read on.Cont.
#TILS $TLSA - StemPrintERYou came for the covid, but will stay for the breast! StemPrintER is a breast cancer diagnostic assay that is generating big interest lately after it emerged ASCO are minded to deem this tech best in class."So what?" I hear you ask. Read on.Cont.
#TILS $TLSA - StemPrintERYou came for the covid, but will stay for the breast! StemPrintER is a breast cancer diagnostic assay that is generating big interest lately after it emerged ASCO are minded to deem this tech best in class."So what?" I hear you ask. Read on.Cont.
#TILS $TLSA - Backers:

ASCO is the leading authority in oncology. An endorsement from ASCO (especially on a diagnostic like this that DOES NOT REQUIRE FDA) is worth gold.

Further, the independent verification is said to be from the prestigious Royal Marsden.

Cont.
#TILS $TLSA - Backers:ASCO is the leading authority in oncology. An endorsement from ASCO (especially on a diagnostic like this that DOES NOT REQUIRE FDA) is worth gold.Further, the independent verification is said to be from the prestigious Royal Marsden.Cont.
#TILS $TLSA - Backers:ASCO is the leading authority in oncology. An endorsement from ASCO (especially on a diagnostic like this that DOES NOT REQUIRE FDA) is worth gold.Further, the independent verification is said to be from the prestigious Royal Marsden.Cont.
#TILS $TLSA - Inflection points

TILS holds a GM TODAY

TILS has its ASCO abstracts released MAY 13TH

TILS has the full ASCO event MAY 29TH

TILS has covid pipeline of news flow on top of this!

So what& #39;s it worth?

Cont.
#TILS $TLSA - Inflection pointsTILS holds a GM TODAYTILS has its ASCO abstracts released MAY 13THTILS has the full ASCO event MAY 29THTILS has covid pipeline of news flow on top of this!So what& #39;s it worth?Cont.
#TILS $TLSA - Inflection pointsTILS holds a GM TODAYTILS has its ASCO abstracts released MAY 13THTILS has the full ASCO event MAY 29THTILS has covid pipeline of news flow on top of this!So what& #39;s it worth?Cont.
#TILS $TLSA - what& #39;s it worth?

TILS will be addressing a $4.64 billion market.

Genomic had the best assay which generated $300M PA revenues. It was bought out by EXACT Nov19 for $2.8B.

Work out TILS P/E on $300M PA or the SP on a takeover.

PS. this tech is close to market
#TILS $TLSA - what& #39;s it worth?TILS will be addressing a $4.64 billion market. Genomic had the best assay which generated $300M PA revenues. It was bought out by EXACT Nov19 for $2.8B. Work out TILS P/E on $300M PA or the SP on a takeover. PS. this tech is close to market
#TILS $TLSA - what& #39;s it worth?TILS will be addressing a $4.64 billion market. Genomic had the best assay which generated $300M PA revenues. It was bought out by EXACT Nov19 for $2.8B. Work out TILS P/E on $300M PA or the SP on a takeover. PS. this tech is close to market
#TILS $TLSA - what& #39;s it worth?TILS will be addressing a $4.64 billion market. Genomic had the best assay which generated $300M PA revenues. It was bought out by EXACT Nov19 for $2.8B. Work out TILS P/E on $300M PA or the SP on a takeover. PS. this tech is close to market
#TILS $TLSA - RNS 06.05.2020

All resolutions passed at GM

TR1 - Morris Silverman, industry professional ups stake from 3.63% to 4.94%
#TILS $TLSA - RNS 06.05.2020All resolutions passed at GMTR1 - Morris Silverman, industry professional ups stake from 3.63% to 4.94%
#TILS $TLSA - RNS 06.05.2020All resolutions passed at GMTR1 - Morris Silverman, industry professional ups stake from 3.63% to 4.94%
You can follow @TakeAIM100.
Tip: mention @twtextapp on a Twitter thread with the keyword “unroll” to get a link to it.

Latest Threads Unrolled:
There are a lot of misconceptions about the Turkish diaspora in Germany. Since i just finished writing an essay about this topic I thought it's time to give other people
Read more
Las mejores calculadoras online en 2020A thread http://totumat.com/2020/11/26/las-mejores-calculadoras-online-en-2020/ Cuando se estudian asignaturas que requieren de cálculos complicados, nada mejor que contar con una buena calculadora.
Read more
Mitigating #ClimateChange is as much about taking up new techs as about leaving others behindMost studies focus on #coal's global downfall but another #energy tech decline is loomingRead my new
Read more